During the past decade, Northern Cancer Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Cancer Institute" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northern Cancer Institute" are "Chromophobe Renal Cell Carcinoma" (1 trials), "Metastatic Kidney Cancer" (1 trials), "Papillary Renal Cell Carcinoma Type 1" (1 trials), "Papillary Renal Cell Carcinoma Type 2" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Northern Cancer Institute" in a lesser frequency.

Most popular intervention types in "Northern Cancer Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (1 trials), "Nivolumab" (1 trials) and "Pembrolizumab plus denosumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northern Cancer Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northern Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Northern Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northern Cancer Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".